Tumor markers in heart failure

Tumor markers in heart failure

It has been widely demonstrated that patients diagnosed with chronic heart failure present high levels of circulating neurohormones and inflammation markers which can secondarily induce an increase of the level of tumor markers such as CA 125, AFP, CEA, CA 15.3 or CA 19-9. This is a literature revie...

Full description

Bibliographic Details
Main Authors:	Nicolae BACALBASA, Alexandra GIREADA, Irina BALESCU, Cristian BALALAU, Mihai DIMITRIU
Format:	Article
Language:	English
Published:	Amaltea Medical Publishing House 2016-03-01
Series:	Romanian Journal of Medical Practice
Subjects:	chronic heart failure ca 125 ca 15.3 cea
Online Access:	https://rjmp.com.ro/articles/2016.1/RJMP_2016_1_Art-03.pdf

Similar Items

Avaliação hormonal e de marcadores séricos em pacientes com abortamento Hormonal and serum marker evaluation in patients with abortion
by: Eddie Fernando Candido Murta, et al.
Published: (1998-03-01)

Clinical significance of detecting CEA, CA199, AFP, HCG, CA153, CA125 in postoperative treatment of patients with ovarian cancer
by: Xue Pan, et al.
Published: (2016-10-01)

Valor diagnóstico de la combinación de nueve marcadores tumorales en neoplasias
by: Ivón Howland Álvarez, et al.
Published: (2016-12-01)

Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
by: Amal Ramadan, et al.
Published: (2021-05-01)

Predictive Role of Serum Tumor Markers in Diagnosis of Pulmonary Tuberculosis
by: Jingjing MA, et al.
Published: (2016-04-01)

Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites
by: Fang Liu, et al.
Published: (2014-05-01)

Role of Serum Tumor Markers in Prognosis of Operable Non-small Cell Lung Cancer Patients
by: LI Shaolei, et al.
Published: (2018-01-01)

Correlation Between Baseline Serum Tumor Markers and Clinical Characteristic Factors in Patients with Advanced Pancreatic Cancer
by: Deng G, et al.
Published: (2020-11-01)

Value and significance of tumor markers as CEA, CA125, SCC-Ag, CA199 and CYFRA21-1 in the diagnosis of cervical cancer
by: Xiao-Juan Wang, et al.
Published: (2017-09-01)

Prognostic value of glycoprotein CA125 and their time-line changes in decompensated heart failure
by: Claudia Josa-Laorden, et al.
Published: (2021-01-01)

The possible role of tumor antigen CA 15-3, CEA and ferritin in malignant and benign disease
by: Nafija Serdarević, et al.
Published: (2012-09-01)

The possible role of tumor antigen CA 15-3, CEA and ferritin in malignant and benign disease
by: Nafija Serdarević, et al.
Published: (2012-09-01)

Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure
by: Jae Yong Yoon, et al.
Published: (2019-07-01)

Diagnostic value of tumour markers Ca-125 and CEA in the diagnostics of malignant pleural fluids
by: Žentiņa Dace, et al.
Published: (2016-04-01)

Clinical significance of serum tumor markers CA153, CA125, CA72-4 and FIB, IL-6 levels detection in ovarian cancer
by: Zhong-Jie Liu, et al.
Published: (2018-01-01)

The diagnostic value of blood level of CEA and CA15-3 tumor markers in breast tumor with axillary lymph node metastases
by: M. Gahremani, et al.
Published: (2007-01-01)

Value of CA19-9, CA125 and CEA combined magnetic resonance imaging in the diagnosis of pancreatic cancer
by: Ying Huang, et al.
Published: (2018-02-01)

Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
by: Guo Junhong, et al.
Published: (2017-05-01)

CA-19-9 as an Emerging Marker of Ovarian Tumour: A Rare Entity
by: Alpana Singh, et al.
Published: (2019-05-01)

Rare primary peritoneal mucinous adenocarcinoma in a 69‐year‐old man
by: Fumiko Satoh, et al.
Published: (2021-09-01)

Influence of Neoadjuvant CAF Chemotherapy on Serum TSGF, CA15-3 and CA125 in Patients with Breast Cancer
by: hang-xiao ZHAO, et al.
Published: (2016-09-01)

Correlation between the Level of the Tumor Markers with the Stage of Liver Fibrosis in Patients with Chronic Hepatitis and Cirrhosis
by: Maryam Heydarpour, et al.
Published: (2011-11-01)

Correlation Between Bone Scintigraphy and Tumor Markers in Patients with Breast Carcinoma
by: Amela Begić, et al.
Published: (2006-02-01)

The Potential Ability of Plaster to Cause Breast Cancer as Indicated by CA15-3 and CEA Antigens in Women Working in Gypsum Factory
by: Ali Abdul Hussein S. AL-Janabi
Published: (2017-07-01)

Avaliação dos valores sérico e pleural dos marcadores tumorais CEA, CYFRA21-1 e CA 15-3 em portadores de derrame pleural Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion
by: Isabella Coimbra Wagner, et al.
Published: (2007-04-01)

Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
by: Ji Hui Choi, et al.
Published: (2018-05-01)

A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme
by: Jun Zhu, et al.
Published: (2021-04-01)

Malignant Melanoma Arising in an Ovarian Mature Cystic Teratoma - A Rare Entity
by: RANJINI KUDVA, et al.
Published: (2015-04-01)

Verifiering av metod för analys av tumörmarkörerna CA 125, CA 15-3 och CA 19-9 på Roche Cobas e411
by: Zulj, Jelena
Published: (2014)

P-STAT3 and IL-17 in tumor tissues enhances the prognostic value of CEA and CA125 in patients with lung adenocarcinoma
by: Xiao-Ke Chen, et al.
Published: (2020-05-01)

Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors
by: Chen F, et al.
Published: (2018-05-01)

Determination of Cancer Antigen CA15-3 and Carcino Embryonic Antigen CEA concentration as Tumor Markers in Patients with Stomach and Colorectal cancers.
by: Rana. K. AL-saady, et al.
Published: (2012-10-01)

Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: An empirical study of different surgical adoptions
by: Ko-Chao Lee, et al.
Published: (2017-02-01)

Effect of rabdosia rubescens combined with new assistant chemotherapy on serum CA199, CEA, CA15-3 and T lymphocyte subsets in patients with breast cancer
by: Lei Xi, et al.
Published: (2018-07-01)

The Role Of Tumor Markers In The Diagnosis And Follow Up In Patients With Pancreatic Cancer
by: Ansam Aladdin Al-Bayatti
Published: (2007-01-01)

Effect of oxaliplatin combined with capeeitabine as chemotherapy on serum CA125, CEA, TPS, Cyfra21-1, CA19-9 and T lymphocyte subsets of post-operative patients with advanced gastric carcinoma
by: Feng Deng, et al.
Published: (2016-08-01)

Assessment of Elevated Serum Tumor Markers Carcinoembryonic Antigen (CEA) and Cancer Antigen 15-3 (CA15-3) among Patients with Different Subtypes of Metastatic Breast Cancer
by: Ali Taghizadeh, et al.
Published: (2019-01-01)

Trousseau's Syndrome Caused by Intrahepatic Cholangiocarcinoma: An Autopsy Case Report and Literature Review
by: Takashi Yuri, et al.
Published: (2014-05-01)

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes
by: Michiko Imamura, et al.
Published: (2018-02-01)

Effect of paclitaxel liposome combined with nedaplatin on serum HE4, CA125, CA19-9, AFP, CEA and T lymphocyte subsets in patients with advanced ovarian cancer
by: Su-Yu Zhu, et al.
Published: (2016-08-01)

Cannot write session to /tmp/vufind_sessions/sess_b9ftbkk0gehqubu5gpg2hqcen5